CDEK
← All drugs Report issue

antigen pulsed dendritic cells

Vaccineexperimental

Clinical trial activity

15 trials · 27 clinical orgs · 0 marketing orgs

Phase 1
6
Phase 2
9
Phase 3
3
Phase 4
0

Earliest trial started Mar 1, 2005 (NCT00834002)

Timeline

2000s

  1. Jan 1, 2005

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • alpha-type-1 dendritic cell-based vaccines
  • alpha-type-1-polarized dendritic cell
  • antigen-loaded cultured dendritic cells
  • antigen pulsed dendritic cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06675201Phase 2Oct 1, 2024Sichuan University
NCT05749627N/AApr 1, 2023Nanchang University
NCT05539365Phase 2Dec 7, 2022State University of New York, Buffalo
NCT05378464Phase 1May 31, 2022University of South Florida, Vaccinex Inc.
NCT04911621Phase 1/Phase 2 (Phase 2)Sep 10, 2021Kom Op Tegen Kanker, Olivia Hendrickx research Fund vzw, Stichting Semmy, University of Antwerp
NCT04912765Phase 2Apr 15, 2021Bristol-Myers Squibb, Government of Singapore
NCT04093323Phase 2Oct 1, 2019National Cancer Institute (NCI), State University of New York, Buffalo
NCT03735589Phase 1/Phase 2 (Phase 2)Jun 15, 2019National Cancer Institute (NCI), State University of New York, Buffalo
NCT03548571Phase 2/Phase 3 (Phase 3)Apr 26, 2018University of Oslo
NCT03387553Early Phase 1 (Phase 1)Apr 6, 2018Department of Defense, University of South Florida
NCT02615574Phase 2Mar 1, 2016University of Pittsburgh
NCT02503150Phase 3Jul 1, 2015Changhai Hospital, Chinese Academy of Medical Sciences, First People's Hospital of Hangzhou, Fudan University, Haixin Biotechnology Co. Ltd, Jiao Tong University, Peking University, People's Liberation Army of China, Second Military Medical University, Zhejiang University
NCT01595594Phase 3Mar 1, 2010Fundação de Amparo à Pesquisa do Estado de São Paulo, University of Sao Paulo
NCT00558051Phase 1Jan 1, 2008University of Pittsburgh
NCT00834002Phase 1Mar 1, 2005University of Antwerp
Showing 15 of 15 trials
Page 1 / 1

Organizations

Research & Development (27)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
State University of New York, BuffaloAcademic/Hospital3312019
National Cancer Institute (NCI)Government2012019
University of AntwerpAcademic/Hospital2222005
University of PittsburghAcademic/Hospital2222008
University of South FloridaAcademic/Hospital2212018
Bristol-Myers SquibbFor profit1012021
Changhai HospitalAcademic/Hospital1012015
Chinese Academy of Medical SciencesAcademic/Hospital1012015
Department of DefenseGovernment1012018
First People's Hospital of HangzhouAcademic/Hospital1012015
Fudan UniversityAcademic/Hospital1012015
Fundação de Amparo à Pesquisa do Estado de São PauloAcademic/Hospital1012010
Government of SingaporeGovernment1112021
Haixin Biotechnology Co. LtdFor profit1012015
Jiao Tong UniversityAcademic/Hospital1012015
Kom Op Tegen KankerAcademic/Hospital1012021
Nanchang UniversityAcademic/Hospital1112023
Olivia Hendrickx research Fund vzwAcademic/Hospital1012021
Peking UniversityAcademic/Hospital1012015
People's Liberation Army of ChinaGovernment1112015
27 organizations
Page 1 / 2